{
  "meta": {
    "title": "Disorders_Of_Pleura_Josa_J_Ventilation_Bronchiectasis_And_Cystic_Fibrosis",
    "url": "https://brainandscalpel.vercel.app/disorders-of-pleura-josa-j-ventilation-bronchiectasis-and-cystic-fibrosis-e89d6c5b.html",
    "scrapedAt": "2025-11-30T08:49:05.101Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid LDH>2/3 Upper normal serum limit</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid Triglyceride>2/3 Upper normal serum limit</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid/serum LDH>0.6 </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural Fluid/serum protein>0.5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in Lights criteria?</span></p>",
      "unique_key": "DT1295561",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295561,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Light's Criteria</strong> are used to distinguish <strong>exudative</strong> from <strong>transudative</strong> pleural effusions. The criteria include:\r\n<ol>\r\n<li>Pleural fluid/serum protein &gt; 0.5</li>\r\n<li>Pleural fluid/serum LDH &gt; 0.6</li>\r\n<li>Pleural fluid LDH &gt; 2/3 of the normal upper serum limit</li>\r\n</ol>\r\n</li>\r\n<li><strong>Triglyceride levels</strong> are not part of Light's criteria; they are more relevant in diagnosing <strong>chylothorax</strong>.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Pleural fluid LDH &gt; 2/3 Upper normal serum limit:</strong> This is part of Light's criteria.</li>\r\n<li><strong>C. Pleural fluid/serum LDH &gt; 0.6:</strong> Correctly included in Light's criteria.</li>\r\n<li><strong>D. Pleural fluid/serum protein &gt; 0.5:</strong> Also part of Light's criteria.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Light's Criteria</strong> help in identifying <strong>exudative effusion</strong>.</li>\r\n<li>Triglycerides are used to assess <strong>chylothorax</strong>, not pleural effusion classification.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Mesothelioma</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxoedema</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Both B and C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of exudative pleural effusion?</span></p>",
      "unique_key": "DT1295625",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295625,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Exudative pleural effusion</strong> results from increased capillary permeability or damage to the pleural surfaces. Causes include infections, malignancies, and inflammatory diseases.</li>\r\n<li><strong>Mesothelioma</strong>, a malignant tumor of the pleura, causes exudative effusion due to pleural irritation, inflammation, and fluid accumulation as tumor cells invade the pleural lining.\r\n<ul>\r\n<li><strong>Exudates</strong> are characterized by high protein content and LDH levels in pleural fluid.</li>\r\n<li>Diagnostic indicators include pleural fluid protein/serum protein ratio &gt;0.5, pleural fluid LDH/serum LDH ratio &gt;0.6, or pleural fluid LDH &gt;2/3 of the upper limit of normal serum LDH.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Light's Criteria</strong> is used to differentiate between exudative and transudative effusions, and mesothelioma typically meets the criteria for an exudative effusion.</li>\r\n</ul>\r\n<p>Causes of Pleural effusion:</p>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501095e38fdf7-3d78-46ec-9fdb-36a4747148bd.jpg\">\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Cirrhosis:</strong> Typically causes <strong>transudative</strong> pleural effusion (hepatic hydrothorax), resulting from fluid accumulation due to low oncotic pressure and portal hypertension.</li>\r\n<li><strong>C. Myxoedema:</strong> Causes <strong>transudative</strong> effusions associated with hypothyroidism and fluid retention. It is not an exudative condition.</li>\r\n<li><strong>D. Both B and C:</strong> While <strong>mesothelioma</strong> causes exudative effusion, <strong>myxoedema</strong> does not. Therefore, this option is incorrect.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Exudative effusions</strong> occur in malignancies like <strong>mesothelioma</strong>, infections, and inflammatory conditions.</li>\r\n<li><strong>Transudative effusions</strong> are due to systemic factors, such as <strong>cirrhosis</strong> and <strong>myxoedema</strong>.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine deaminase</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon Y in pleural fluid</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid Culture for AFB</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following in pleural fluid is sensitive and specific test for diagnosis of tubercular pleural effusion?</span></p>",
      "unique_key": "DT1295626",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295626,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Tubercular pleural effusion</strong> is typically exudative, indicating high protein levels in the pleural fluid.</li>\r\n<li><strong>Adenosine deaminase (ADA)</strong> levels &gt;40 IU/L in pleural fluid are both sensitive and specific for diagnosing tubercular pleuritis.</li>\r\n<li><strong>Interferon-gamma (IFN-&gamma;)</strong> levels &gt;140 pg/mL in pleural fluid are also considered specific for TB-related effusions.</li>\r\n<li><strong>Pleural fluid culture for AFB (Acid-Fast Bacilli)</strong> and pleural biopsy are specific tests but have lower sensitivity, especially in early disease stages.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Adenosine deaminase:</strong> While <strong>ADA</strong> is highly sensitive and specific, using <strong>IFN-&gamma;</strong> alongside it increases diagnostic accuracy.</li>\r\n<li><strong>B. Interferon-gamma: IFN-&gamma;</strong> is also sensitive and specific, but <strong>ADA</strong> enhances diagnostic utility when combined.</li>\r\n<li><strong>C. Pleural fluid Culture for AFB:</strong> Although specific, <strong>culture for AFB</strong> has low sensitivity, often leading to false negatives, especially in pleural TB.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>ADA &gt;40 IU/L</strong> and <strong>IFN-&gamma; &gt;140 pg/mL</strong> are <strong>sensitive and specific</strong> tests for diagnosing tubercular pleural effusion.</li>\r\n<li><strong>Culture</strong> and <strong>biopsy</strong> are useful but limited by low sensitivity.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid total cholesterol >250 mg/dL</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid  LDL >110mg/dL</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid  Triglyceride >110 mg/dL</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the Above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Presence of which of the following in pleural fluid confirms the diagnosis of Chylothorax?</span></p>",
      "unique_key": "DT1295627",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295627,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Chylothorax</strong> is defined by the <strong>presence of chyle</strong> in the pleural space, typically caused by traumatic or procedural disruption of the <strong>thoracic duct</strong> or tumors in the mediastinum.</li>\r\n<li><strong>Thoracentesis</strong> reveals milky fluid, and a pleural fluid <strong>triglyceride level &gt;110 mg/dL</strong> is diagnostic of <strong>chylothorax</strong>.</li>\r\n<li>Causes of <strong>chylothorax</strong> include trauma, surgery, or tumors in the mediastinum.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Total cholesterol &gt;250 mg/dL:</strong> High cholesterol does not confirm <strong>chylothorax</strong> but can indicate a cholesterol effusion.</li>\r\n<li><strong>B. LDL &gt;110 mg/dL:</strong> LDL is not used as a specific marker for <strong>chylothorax</strong> diagnosis.</li>\r\n<li><strong>D. All of the Above:</strong> Only <strong>triglyceride &gt;110 mg/dL</strong> is specific for confirming <strong>chylothorax</strong>.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Pleural fluid triglyceride &gt;110 mg/dL</strong> is <strong>confirmatory</strong> for <strong>chylothorax</strong>.</li>\r\n<li>Diagnosis may involve <strong>mediastinal CT</strong> and <strong>lymphangiogram</strong> to identify the cause.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid Lactate dehydrogenase</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid NT-Pro BNP</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid Creatinine phosphokinase</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural fluid Troponin T</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following biomarker in pleural fluid can be used to confirm the diagnosis of Pleural effusion secondary to Congestive heart failure?</span></p>",
      "unique_key": "DT1295635",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295635,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>A pleural fluid <strong>NT-Pro BNP level &gt;1500 pg./mL</strong> is <strong>diagnostic</strong> of pleural effusion secondary to <strong>Congestive Heart Failure (CHF)</strong>.</li>\r\n<li>This test is specific for <strong>heart failure-related effusion</strong>, while other markers like <strong>LDH, CPK, and Troponin T</strong> are not specific for pleural effusion caused by CHF.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Pleural fluid LDH:</strong> Elevated in exudative effusions but not specific for <strong>CHF-related effusion</strong>.</li>\r\n<li><strong>C. Pleural fluid CPK:</strong> Marker for muscle damage, not useful for diagnosing <strong>CHF-related pleural effusion</strong>.</li>\r\n<li><strong>D. Pleural fluid Troponin T:</strong> Indicates myocardial injury, not related to <strong>pleural effusion</strong> in CHF.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>NT-Pro BNP &gt;1500 pg./mL</strong> in pleural fluid is <strong>diagnostic</strong> for <strong>CHF-related pleural effusion</strong>.</li>\r\n<li>Knowing other pleural fluid markers helps differentiate types of pleural effusions, such as <strong>hematocrit</strong> for <strong>hemothorax</strong></li>\r\n</ul>\r\n ",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Streptokinase</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenecteplase</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs is used as sclerosing agent for recurrent pleural effusion?</span></p>",
      "unique_key": "DT1295641",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295641,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Pleurodesis</strong> is performed to prevent <strong>recurrent pleural effusion</strong> (e.g., in malignancies).</li>\r\n<li><strong>Doxycycline</strong> induces <strong>pleural adhesion</strong> by causing inflammation, leading to <strong>fibrosis</strong> and obliteration of the pleural space.</li>\r\n<li>Other commonly used agents:\r\n<ul>\r\n<li><strong>Talc:</strong> High success rate.</li>\r\n<li><strong>Bleomycin:</strong> Used in patients with contraindications to talc or tetracyclines.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Minocycline</strong> is also effective, similar to doxycycline.</li>\r\n</ul>\r\n<p><strong>Other sclerosing agents include:</strong></p>\r\n<ul>\r\n<li><strong>Corynebacterium parvum</strong> with <strong>methylprednisolone acetate</strong></li>\r\n<li><strong>Fluorouracil, Erythromycin</strong> (less common).</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Streptokinase:</strong> Thrombolytic, not for pleurodesis.</li>\r\n<li><strong>B. Tenecteplase:</strong> Used for clots, not pleurodesis.</li>\r\n<li><strong>D. All of the above:</strong> Incorrect, as streptokinase and tenecteplase are not sclerosing agents.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Doxycycline</strong> is a commonly used <strong>pleurodesis agent</strong> for recurrent pleural effusion.</li>\r\n<li><strong>Talc</strong> is highly effective in <strong>malignant pleural effusions</strong>.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary spontaneous pneumothorax</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Secondary pneumothorax</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male is brought to medical emergency after trauma. He is severely dyspnic. The trachea is shifted to left and apex beat is also displaced to left side. Hyper resonant note is present throughout the right side of chest. What is the diagnosis?</span></p>",
      "unique_key": "DT1295648",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295648,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Tension pneumothorax</strong> is a <strong>medical emergency</strong> caused by the accumulation of air in the pleural cavity, creating positive pressure.</li>\r\n<li><strong>Signs:</strong>\r\n<ul>\r\n<li><strong>Severe dyspnea</strong>.</li>\r\n<li><strong>Tracheal deviation</strong> and <strong>apex beat shifted</strong> to the opposite side.</li>\r\n<li><strong>Hyper-resonance</strong> on percussion over the affected side.</li>\r\n</ul>\r\n</li>\r\n<li>Immediate <strong>needle decompression</strong> is needed to relieve the pressure.</li>\r\n</ul>\r\n<p><strong>Other types:</strong></p>\r\n<ul>\r\n<li><strong>Primary spontaneous pneumothorax:</strong> Occurs without trauma, usually in healthy individuals.</li>\r\n<li><strong>Secondary pneumothorax:</strong> Associated with lung disease like COPD.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B. Primary spontaneous pneumothorax:</strong> No history of trauma or lung disease in this case.</li>\r\n<li><strong>C. Secondary pneumothorax:</strong> Occurs with underlying lung pathology, not a trauma case.</li>\r\n<li><strong>D. None of the above:</strong> Incorrect, as tension pneumothorax matches the clinical presentation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Tension pneumothorax</strong> is a life-threatening condition that requires <strong>immediate intervention</strong> (needle decompression).</li>\r\n<li><strong>Tracheal deviation</strong> and <strong>hyper-resonant note</strong> are key findings in <strong>tension pneumothorax</strong>.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension pneumothorax</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumomediastinum</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Massive Pleural Effusion</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Type 2 respiratory failure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Hamman's sign is seen in which of the following clinical condition?</span></p>",
      "unique_key": "DT1295657",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295657,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Hamman's sign:</strong> A characteristic <strong>crunching or clicking noise</strong> synchronous with the heartbeat, best heard in the <strong>left lateral decubitus position</strong>.</li>\r\n<li><strong>Associated Condition:</strong> Indicates <strong>pneumomediastinum</strong> - the presence of air in the mediastinum.</li>\r\n</ul>\r\n<p><strong>Key Points on Pneumomediastinum:</strong></p>\r\n<ul>\r\n<li><strong>Causes:</strong>\r\n<ul>\r\n<li>Alveolar rupture leading to air dissection into the mediastinum.</li>\r\n<li>Esophageal perforation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinical Findings:</strong>\r\n<ul>\r\n<li><strong>Subcutaneous emphysema</strong> in the suprasternal notch.</li>\r\n<li>Hamman's sign is a significant indicator.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Tension pneumothorax:</strong> Characterized by tracheal deviation and hyper-resonance, not Hamman's sign.</li>\r\n<li><strong>C. Massive pleural effusion:</strong> Presents with dullness on percussion, no crunching sound.</li>\r\n<li><strong>D. Type 2 respiratory failure:</strong> Related to hypoventilation and CO2 retention, not specific signs like Hamman's sign.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Hamman's sign</strong> is a crucial clinical indicator of <strong>pneumomediastinum</strong>.</li>\r\n<li>Recognizing this sign can aid in diagnosing conditions involving air in the mediastinum, potentially stemming from serious underlying issues.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 72,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnoea</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Central hypoventilation syndrome</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Obesity hypoventilation syndrome</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Morbid obesity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An obese male with BMI of 34 kg/m2 and history of excessive snoring during night comes for evaluation. Polysomnography reveals obstructive sleep apnoea. ABG shows PaCO2 of 50 mmHg at normal room air. What is the diagnosis?</span></p>",
      "unique_key": "DT1295666",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295666,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Obesity Hypoventilation Syndrome (OHS):</strong> Characterized by:\r\n<ul>\r\n<li><strong>Obesity:</strong> BMI &gt;30 kg/m<sup>2</sup> (the patient has a BMI of 34 kg/m<sup>2</sup>).</li>\r\n<li><strong>Hypoventilation:</strong> PaCO<sub>2</sub> &gt;45 mmHg at room air (patient's PaCO<sub>2</sub> is 50 mmHg).</li>\r\n<li><strong>Obstructive Sleep Apnea:</strong> Presence of obstructive apneas/hypopneas contributes to the condition.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501094da561bc-3951-4bb8-85b6-e951b08c7aef.jpg\">\r\n<p><strong>Key Points:</strong></p>\r\n<ul>\r\n<li><strong>Diagnosis Criteria for OHS:</strong>\r\n<ul>\r\n<li>Presence of obesity and hypoventilation.</li>\r\n<li>Elevated PaCO<sub>2</sub> during wakefulness.</li>\r\n<li>Symptoms of obstructive sleep apnea (e.g., excessive snoring).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Obstructive sleep apnea:</strong> While present, it does not account for the elevated PaCO<sub>2</sub> and other features.</li>\r\n<li><strong>B. Central hypoventilation syndrome:</strong> Characterized by central respiratory center failure, not solely related to obesity.</li>\r\n<li><strong>D. Morbid obesity:</strong> Defined as BMI &gt;35 kg/m<sup>2</sup>; the patient's BMI is 34 kg/m<sup>2</sup>, thus not applicable.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The diagnosis is <strong>Obesity Hypoventilation Syndrome</strong> due to the combination of obesity, elevated PaCO<sub>2</sub>, and obstructive sleep apnea.</li>\r\n<li>Recognizing this syndrome is crucial for managing patients at risk for respiratory complications associated with obesity.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 83,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Ondine's curse</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Apnea</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypopnea</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory effort related arousal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a central hypoventilation syndrome?</span></p>",
      "unique_key": "DT1295673",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295673,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Central Hypoventilation Syndrome:</strong> Characterized by an <strong>absent respiratory response to hypoxia/hypercapnia</strong>, leading to mild elevation of PaCO<sub>2</sub> while awake and significantly elevated levels during non-REM sleep.</li>\r\n<li><strong>Patient Ability:</strong> Individuals can <strong>normalize PaCO<sub>2</sub> during exercise and REM sleep</strong>.</li>\r\n<li><strong>Management:</strong> Often requires <strong>NIPPV or mechanical ventilation</strong>; may consider <strong>phrenic nerve or diaphragmatic pacing</strong> in specialized centers.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B) Apnea:</strong> Defined as cessation of airflow for <strong>&ge;10 seconds</strong>; does not specifically indicate <strong>central hypoventilation</strong>.</li>\r\n<li><strong>C) Hypopnea:</strong> A <strong>&ge;30% reduction</strong> in airflow for at least <strong>10 seconds</strong>, accompanied by desaturation; this is a different entity.</li>\r\n<li><strong>D) Respiratory effort-related arousal (RERA):</strong> Represents <strong>partial obstruction</strong> with increasing inspiratory effort, not central hypoventilation.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Ondine's curse is a <strong>central hypoventilation syndrome</strong> requiring specific management strategies.</li>\r\n<li>Differentiate from <strong>apnea, hypopnea</strong>, and <strong>RERA</strong> as they represent distinct disorders with varying characteristics.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 91,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Electroencephalography</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Electrooculography</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Polysomnography</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">All three (A, B and C) is required for confirmation of diagnosis.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is used for confirmation of the diagnosis of obstructive sleep Apnoea?</span></p>",
      "unique_key": "DT1295675",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295675,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Gold Standard:</strong> The <strong>overnight polysomnogram (PSG)</strong> is the gold standard for diagnosing obstructive sleep apnea (OSA).</li>\r\n<li><strong>Functionality:</strong>\r\n<ul>\r\n<li><strong>Electroencephalography (EEG):</strong> Records brain activity to assess <strong>REM and non-REM sleep</strong>.</li>\r\n<li><strong>Electrooculography (EOG):</strong> Records <strong>ocular movements</strong> but does not confirm OSA.</li>\r\n</ul>\r\n</li>\r\n<li><strong>OSA Diagnosis Criteria:</strong> Symptoms include nocturnal breathing disturbances and daytime sleepiness with an <strong>apnea-hypopnea index (AHI)</strong> of <strong>&ge;5 episodes/hour</strong> during sleep.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A) Electroencephalography:</strong> While useful in sleep studies, it does not specifically confirm OSA.</li>\r\n<li><strong>B) Electrooculography:</strong> Also does not provide confirmation of obstructive sleep apnea.</li>\r\n<li><strong>D) All three (A, B, and C):</strong> Not required, as polysomnography alone confirms the diagnosis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Polysomnography</strong> is essential for diagnosing <strong>obstructive sleep apnea</strong>.</li>\r\n<li>Understand the role of <strong>EEG and EOG</strong> in sleep studies, but they are not diagnostic for OSA on their own.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 103,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous positive airway pressure (CPAP)</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Sedatives</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Uvulopalatopharyngoplasty</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Upper airway Neurostimulation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most effective therapy for Management of Obstructive sleep apnoea?</span></p>",
      "unique_key": "DT1295678",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295678,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>CPAP Efficacy: Continuous Positive Airway Pressure (CPAP)</strong> is the most effective therapy for managing obstructive sleep apnea (OSA) as it maintains positive pressure throughout the breathing cycle, ensuring the airway remains open.</li>\r\n<li><strong>Avoidance of Sedatives:</strong> Sedative and hypnotic medications should be <strong>avoided</strong> as they can exacerbate OSA symptoms.</li>\r\n<li><strong>Alternative Treatments:</strong> Other options include:\r\n<ul>\r\n<li><strong>Oral appliances:</strong> Used to reposition the jaw and tongue.</li>\r\n<li><strong>Surgery:</strong> Uvulopalatopharyngoplasty (UPPP) is the most common surgical intervention.</li>\r\n<li><strong>Upper airway neurostimulation:</strong> Considered for refractory moderate to severe OSA (AHI &gt;15).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B) Sedatives:</strong> These can worsen airway obstruction and are not recommended for OSA management.</li>\r\n<li><strong>C) Uvulopalatopharyngoplasty:</strong> While it can be effective, it is not as effective as CPAP for most patients.</li>\r\n<li><strong>D) Upper airway neurostimulation:</strong> Used only in specific cases of refractory OSA, making it less effective as a first-line treatment.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>CPAP</strong> is the <strong>gold standard</strong> therapy for managing <strong>obstructive sleep apnea</strong>.</li>\r\n<li>Alternative treatments like <strong>surgery and oral appliances</strong> are less effective compared to CPAP and are considered based on individual patient needs.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive sleep apnoea</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Central sleep Apnoea</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Both B and C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cheyne-strokes breathing is a feature of</span></p>",
      "unique_key": "DT1295681",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295681,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Cheyne-Stokes Breathing:</strong> Characterized by a pattern of <strong>hyperventilation</strong> alternating with <strong>apnea</strong>, indicative of increased sensitivity of the respiratory center to <strong>PaCO<sub>2</sub></strong>.</li>\r\n<li><strong>Central Sleep Apnea:</strong> In this condition, there is a heightened sensitivity of respiratory centers to carbon dioxide levels, leading to cycles of apnea and hyperventilation.</li>\r\n<li><strong>Congestive Heart Failure:</strong> Prolonged circulation time between the pulmonary capillaries and carotid chemoreceptors also results in the alternating breathing pattern observed in Cheyne-Stokes respiration.</li>\r\n<li><strong>Other Causes:</strong> Can include <strong>opioid medication</strong> use and <strong>breathing at high altitudes</strong>.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A) Obstructive Sleep Apnea:</strong> This is characterized by airway obstruction rather than the central regulation issues seen in Cheyne-Stokes breathing.</li>\r\n<li><strong>B) Central Sleep Apnea:</strong> While this is a correct option, it alone does not encompass the full range of conditions associated with Cheyne-Stokes breathing.</li>\r\n<li><strong>C) Congestive Heart Failure:</strong> This condition contributes to Cheyne-Stokes breathing, but without including central sleep apnea, the answer would be incomplete.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Cheyne-Stokes breathing</strong> is associated with <strong>both central sleep apnea</strong> and <strong>congestive heart failure</strong>, due to their effects on respiratory sensitivity.</li>\r\n<li>Understanding the underlying mechanisms aids in identifying and managing conditions that present with this breathing pattern.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic pulmonary fibrosis</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive lung disease</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic Fibrosis</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary artery hypertension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most common indication for lung transplantation worldwide?</span></p>",
      "unique_key": "DT1295684",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295684,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Most Common Indication: Chronic Obstructive Pulmonary Disease (COPD)</strong> is the leading cause for lung transplantation globally, driven by its prevalence and impact on quality of life.</li>\r\n<li><strong>Other Indications:</strong>\r\n<ul>\r\n<li><strong>Idiopathic Pulmonary Fibrosis:</strong> Although significant, it is not as prevalent as COPD.</li>\r\n<li><strong>Cystic Fibrosis:</strong> A common cause but less frequent compared to obstructive lung disease.</li>\r\n<li><strong>Pulmonary Artery Hypertension:</strong> While notable, it does not surpass COPD in frequency for transplantation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A) Idiopathic Pulmonary Fibrosis:</strong> Important but less common than COPD as an indication for transplantation.</li>\r\n<li><strong>C) Cystic Fibrosis:</strong> Relevant but not the most common; primarily seen in younger populations.</li>\r\n<li><strong>D) Pulmonary Artery Hypertension:</strong> A serious condition that can lead to transplantation but is not the most common indication.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Obstructive lung disease</strong>, especially COPD, remains the <strong>most common indication</strong> for lung transplantation worldwide.</li>\r\n<li>Awareness of common indications helps in prioritizing donor lungs and improving patient outcomes in transplantation.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic bronchitis</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchiectasis</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Emphysema</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40 years old male presents with productive cough with profuse expectoration. He also reports dyspnoea on exertion which is insidious onset gradually progressive. Xray shows tram track sign. What is the diagnosis?</span></p>",
      "unique_key": "DT1295687",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295687,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Bronchiectasis:</strong>\r\n<ul>\r\n<li><strong>Definition:</strong> An irreversible airway dilation, which can be focal or diffuse.</li>\r\n<li><strong>Types:</strong> The most common form is cylindrical or tubular bronchiectasis.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Clinical Manifestations:</strong>\r\n<ul>\r\n<li><strong>Persistent productive cough:</strong> Characterized by the production of <strong>thick, tenacious sputum</strong>.</li>\r\n<li><strong>Dyspnea on exertion:</strong> Gradually progressive, indicating worsening respiratory function.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Imaging Findings:</strong>\r\n<ul>\r\n<li><strong>X-ray:</strong> May show <strong>tram track sign</strong>, which indicates parallel linear opacities due to bronchial wall thickening, but is less sensitive.</li>\r\n<li><strong>HRCT Chest:</strong> The imaging modality of choice, showing:\r\n<ul>\r\n<li><strong>Airway dilation</strong> (tram tracks or signet-ring sign)</li>\r\n<li><strong>Lack of bronchial tapering</strong></li>\r\n<li><strong>Bronchial wall thickening</strong></li>\r\n<li><strong>Inspissated secretions</strong> (tree-in-bud pattern)</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A) Chronic bronchitis:</strong>\r\n<ul>\r\n<li>Typically presents with a productive cough and sputum but does not show tram track sign and involves different pathological changes.</li>\r\n</ul>\r\n</li>\r\n<li><strong>C) Emphysema:</strong>\r\n<ul>\r\n<li>Characterized by the destruction of alveoli and leads to different clinical and radiological findings, such as hyperinflation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>D) Both A and B:</strong>\r\n<ul>\r\n<li>While chronic bronchitis may coexist with bronchiectasis, the presence of tram track sign and the clinical presentation strongly point to bronchiectasis.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Bronchiectasis is characterized by irreversible airway dilation and significant sputum production.</strong></li>\r\n<li><strong>X-ray findings such as the tram track sign, alongside clinical symptoms, strongly support the diagnosis.</strong></li>\r\n</ul>\r\n ",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium avium complex infection</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital Immunodeficiency</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Idiopathic pulmonary Fibrosis</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a cause of bronchiectasis predominantly involving middle lobe of the lung?</span></p>",
      "unique_key": "DT1295689",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295689,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Mycobacterium avium complex (MAC) infection:</strong> This is the primary cause of bronchiectasis in the middle lobe, leading to localized damage and dilation of the bronchi.</li>\r\n<li><strong>Congenital Immunodeficiency:</strong> While it can lead to bronchiectasis, it does not specifically predominate in the middle lobe.</li>\r\n<li><strong>Idiopathic Pulmonary Fibrosis:</strong> This condition typically affects lung parenchyma rather than causing localized bronchiectasis in the middle lobe.</li>\r\n<li><strong>Predominant involvement of lobes:</strong>\r\n<ul>\r\n<li><strong>Lower lobe:</strong> Scleroderma (due to recurrent aspiration).</li>\r\n<li><strong>Middle lobe:</strong> MAC infection.</li>\r\n<li><strong>Upper lobe:</strong> Post-radiation.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250109892f08d2-8672-400b-a608-9dd7de5da1cb.jpg\">\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B. Congenital Immunodeficiency:</strong> Not primarily associated with the middle lobe.</li>\r\n<li><strong>C. Idiopathic Pulmonary Fibrosis:</strong> Does not cause bronchiectasis localized to the middle lobe.</li>\r\n<li><strong>D. All of the above:</strong> Incorrect as MAC is the only condition specifically linked to the middle lobe.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Mycobacterium avium complex is the primary cause of middle lobe bronchiectasis.</li>\r\n<li>Other conditions like congenital immunodeficiency and idiopathic pulmonary fibrosis are not specific to this lobe.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 151,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudomonas</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Legionella</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Clostridium</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Bordetella</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is common organism causing infection and exacerbation in Bronchiectasis?</span></p>",
      "unique_key": "DT1295690",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295690,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Pseudomonas aeruginosa:</strong> This is the most common organism associated with infections and exacerbations in bronchiectasis, especially in patients with underlying conditions like cystic fibrosis.</li>\r\n<li><strong>Haemophilus influenzae:</strong> Also frequently implicated, alongside Pseudomonas, in exacerbations of bronchiectasis.</li>\r\n<li><strong>Legionella:</strong> Typically associated with atypical pneumonia, not common in bronchiectasis exacerbations.</li>\r\n<li><strong>Clostridium:</strong> Generally not involved in bronchiectasis-related infections.</li>\r\n<li><strong>Bordetella:</strong> Primarily linked to whooping cough and not significant in bronchiectasis exacerbations.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B. Legionella:</strong> Less relevant to bronchiectasis; associated more with atypical pneumonia.</li>\r\n<li><strong>C. Clostridium:</strong> Not a common pathogen in respiratory infections related to bronchiectasis.</li>\r\n<li><strong>D. Bordetella:</strong> Primarily associated with pertussis, not typically involved in bronchiectasis.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>Pseudomonas is a key pathogen in bronchiectasis exacerbations.</li>\r\n<li>Empirical antibiotic treatment for exacerbations should cover both Pseudomonas and Haemophilus influenzae.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent infection</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Massive Haemoptysis</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary hypertension</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a complication of Bronchiectasis?</span></p>",
      "unique_key": "DT1295692",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295692,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Recurrent infection:</strong> Common complication due to the accumulation of secretions and impaired clearance in bronchiectasis.</li>\r\n<li><strong>Massive haemoptysis:</strong> Can occur as a complication due to injury to superficial mucosal vessels, leading to significant bleeding.</li>\r\n<li><strong>Pulmonary hypertension:</strong> Although rare, it can develop in patients with severe bronchiectasis as a result of chronic hypoxia.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Recurrent infection:</strong> Clearly a known complication in bronchiectasis patients.</li>\r\n<li><strong>B. Massive haemoptysis:</strong> Well-documented complication resulting from airway damage.</li>\r\n<li><strong>C. Pulmonary hypertension:</strong> Although not very common, it is still recognized as a potential complication.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>All listed options (A, B, and C) are indeed complications of bronchiectasis.</li>\r\n<li>\"None of the above\" is correct as all are recognized complications associated with bronchiectasis.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Kartagener syndrome</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha 1 antitrypsin deficiency</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystic Fibrosis</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Mounier-Kuhn Syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">10 years old male with history of recurrent chest infection comes. For evaluation. CT chest is suggestive of Bronchiectasis. Mother also gives history suggestive of failure to thrive and steatorrhea. Fasting blood sugar is also impaired. What is the most likely diagnosis?</span></p>",
      "unique_key": "DT1295696",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295696,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Cystic Fibrosis (CF):</strong> Characterized by recurrent chest infections leading to bronchiectasis, along with pancreatic insufficiency causing steatorrhea and impaired fasting blood sugar due to endocrine involvement.</li>\r\n<li><strong>Kartagener syndrome:</strong> A genetic disorder with situs inversus, chronic sinusitis, and bronchiectasis; does not account for pancreatic insufficiency or steatorrhea.</li>\r\n<li><strong>Alpha 1 antitrypsin deficiency:</strong> Primarily affects the liver and lungs but does not typically cause gastrointestinal symptoms like steatorrhea.</li>\r\n<li><strong>Mounier-Kuhn syndrome:</strong> Characterized by tracheobronchial dilation but not associated with pancreatic insufficiency or recurrent infections in childhood.</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Kartagener syndrome:</strong> Does not explain the gastrointestinal symptoms or recurrent infections due to exocrine pancreatic insufficiency.</li>\r\n<li><strong>B. Alpha 1 antitrypsin deficiency:</strong> While it can cause lung issues, it is less likely to present with the described gastrointestinal symptoms.</li>\r\n<li><strong>D. Mounier-Kuhn Syndrome:</strong> Does not match the presentation of steatorrhea and recurrent infections.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The combination of recurrent chest infections, bronchiectasis, failure to thrive, and steatorrhea strongly indicates Cystic Fibrosis.</li>\r\n<li>Cystic Fibrosis is associated with both exocrine pancreatic insufficiency and recurrent pulmonary infections.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Meconium ileus in newborns</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Infertility</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Bronchial asthma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a clinical Manifestation of Cystic Fibrosis?</span></p>",
      "unique_key": "DT1295701",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295701,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Cystic Fibrosis (CF):</strong> An autosomal recessive disorder affecting epithelial tissues, characterized by a defective anion channel that leads to thick secretions obstructing airways and ducts.</li>\r\n<li><strong>Clinical Manifestations:</strong>\r\n<ul>\r\n<li><strong>Respiratory:</strong> Recurrent infections, bronchiectasis.</li>\r\n<li><strong>Pancreatic:</strong> Severe loss of exocrine function causing malabsorption and failure to thrive; diabetes occurs in about 30% of cases.</li>\r\n<li><strong>Hepatobiliary:</strong> Obstruction of intrahepatic bile ducts and fibrosis leading to cirrhosis.</li>\r\n<li><strong>Reproductive:</strong> Infertility due to involution of the vas deferens; 99% of males are infertile.</li>\r\n<li><strong>Gastrointestinal:</strong> Meconium ileus occurs in 10-20% of neonates at birth.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Cirrhosis:</strong> Common due to bile duct obstruction and liver damage.</li>\r\n<li><strong>B. Meconium ileus in newborns:</strong> A classic early presentation of CF.</li>\r\n<li><strong>C. Infertility:</strong> Nearly universal in males with CF due to reproductive tract abnormalities.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>Cystic Fibrosis</strong> manifests through respiratory, gastrointestinal, hepatobiliary, and reproductive issues, but <strong>bronchial asthma</strong> is not a direct manifestation of CF.</li>\r\n<li>Understanding the varied clinical presentations of CF helps in its timely diagnosis and management.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Deletion of single phenylalanine residue at 508 position of cystic fibrosis transmembrane conductance regulator [CFTR]</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">G551D (a glycine to aspartic acid replacement at CFTR position 551)</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">G542X - Premature stop codon at 542 position</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">R553X - premature stop codon at 553</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is most common mutation causing cystic fibrosis?</span></p>",
      "unique_key": "DT1295706",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295706,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Cystic Fibrosis (CF):</strong> Caused by mutations in the CFTR gene, leading to defective chloride channels and thick secretions.</li>\r\n<li><strong>Common Mutations:</strong>\r\n<ul>\r\n<li><strong>F508del Mutation:</strong>\r\n<ul>\r\n<li>Most prevalent mutation, present in up to <strong>90%</strong> of CF patients.</li>\r\n<li>Characterized by the deletion of a single phenylalanine residue at position <strong>508</strong>, causing protein misfolding and degradation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>G551D Mutation:</strong>\r\n<ul>\r\n<li>Affects about <strong>4%</strong> of patients; causes altered channel gating (class III defect).</li>\r\n</ul>\r\n</li>\r\n<li><strong>Nonsense Mutations (G542X, R553X):</strong>\r\n<ul>\r\n<li>Lead to premature termination codons, resulting in truncated proteins and severe disease (class I defects).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>B. G551D:</strong> Less common, primarily a gating defect.</li>\r\n<li><strong>C. G542X:</strong> A rare mutation leading to premature stop codon, not the most common.</li>\r\n<li><strong>D. R553X:</strong> Another premature stop codon, also not prevalent compared to F508del.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>F508del mutation</strong> is the most common cause of cystic fibrosis, significantly impacting patient prognosis.</li>\r\n<li>Understanding mutation types aids in targeted therapies and genetic counseling for CF.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweat chloride >60 mmol/K on sweat chloride testing.</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of CF causing pathogenic mutation on genetic testing</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasal transmembrane epithelial potential difference measurement consistent with CF.</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The confirmatory test for diagnosis of cystic fibrosis is?</span></p>",
      "unique_key": "DT1295708",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295708,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Diagnosis of Cystic Fibrosis:</strong> Involves multiple confirmatory tests in the presence of suggestive clinical symptoms.</li>\r\n<li><strong>Key Tests:</strong>\r\n<ul>\r\n<li><strong>Sweat Chloride Test:</strong>\r\n<ul>\r\n<li>Elevated sweat chloride &ge;60 mmol/L is diagnostic for CF.</li>\r\n<li>Normal range: &lt;30 mmol/L; intermediate: 30-59 mmol/L.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Genetic Testing:</strong>\r\n<ul>\r\n<li>Identification of biallelic CFTR pathogenic variants is crucial for confirmation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Nasal Potential Difference (NPD) Measurement:</strong>\r\n<ul>\r\n<li>Measures CFTR function; abnormal results can confirm CF, especially when other tests are inconclusive.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. Sweat Chloride &gt;60 mmol/L:</strong> Alone, this is not a comprehensive confirmatory test; needs to be interpreted with clinical context.</li>\r\n<li><strong>B. Presence of CF-causing mutation:</strong> Important but not sufficient alone for diagnosis without corroborating evidence.</li>\r\n<li><strong>C. NPD Measurement:</strong> While indicative, it is usually used when other tests are inconclusive; not a standalone confirmatory test.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>All three tests</strong> - sweat chloride, genetic testing, and NPD-are critical for confirming cystic fibrosis.</li>\r\n<li>A <strong>comprehensive approach</strong> enhances diagnostic accuracy and guides effective management.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of CF causing pathogenic mutation on genetic testing</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood immnoreactive trypsinogen (a test used in newborn screening)</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasal transmembrane epithelial potential difference measurement consistent with CF.</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweat chloride >60 mmol/K on sweat chloride testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following test is used for Neonatal screening of cystic Fibrosis in suspected cases?</span></p>",
      "unique_key": "DT1295709",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295709,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Neonatal Screening for Cystic Fibrosis:</strong></p>\r\n<ul>\r\n<li><strong>Blood Immunoreactive Trypsinogen (IRT) Test:</strong>\r\n<ul>\r\n<li>This is the primary screening test for detecting cystic fibrosis in newborns.</li>\r\n<li>Elevated levels of IRT suggest the possibility of CF and necessitate further testing.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Confirmatory Tests:</strong>\r\n<ul>\r\n<li>If the IRT test is positive, any of the following confirmatory tests can be performed:\r\n<ul>\r\n<li>Sweat chloride test</li>\r\n<li>Genetic testing for CF-causing mutations</li>\r\n<li>Nasal potential difference measurement</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. CF-causing mutation on genetic testing:</strong> This is a confirmatory test, not a screening test.</li>\r\n<li><strong>C. Nasal transmembrane epithelial potential difference:</strong> Used for confirmation, not for initial screening.</li>\r\n<li><strong>D. Sweat chloride testing:</strong> While diagnostic, it is not used as a neonatal screening method.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li>The <strong>blood immunoreactive trypsinogen test</strong> is essential for neonatal screening of cystic fibrosis.</li>\r\n<li>Positive results should lead to follow-up with confirmatory tests to establish a definitive diagnosis.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">IVACAFTOR</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">LUMACAFTOR</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">TAZACAFTOR</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is newly approved therapy in Cystic Fibrosis?</span></p>",
      "unique_key": "DT1295711",
      "question_audio": null,
      "question_video": null,
      "map_id": 1295711,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Newly Approved Therapies for Cystic Fibrosis:</strong></p>\r\n<ul>\r\n<li><strong>IVACAFTOR:</strong>\r\n<ul>\r\n<li>Enhances CFTR channel opening and ion transport, specifically addressing the G551D mutation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Lumacaftor and Tezacaftor:</strong>\r\n<ul>\r\n<li>These are \"corrector\" molecules that help in proper protein folding and trafficking for patients with the F508del mutation.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Management Components:</strong>\r\n<ul>\r\n<li><strong>Anti-inflammatory medications</strong> and <strong>bronchodilators</strong>.</li>\r\n<li><strong>Antibiotic therapy</strong> (oral or aerosolized) for Pseudomonas aeruginosa infections.</li>\r\n<li><strong>Recombinant DNase aerosols</strong> to reduce mucus viscosity.</li>\r\n<li><strong>Nebulized hypertonic saline</strong> to aid in mucociliary clearance.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<p><strong>Why Not Other Options:</strong></p>\r\n<ul>\r\n<li><strong>A. IVACAFTOR:</strong> While it is a treatment for CF, it is not the only newly approved therapy.</li>\r\n<li><strong>B. LUMACAFTOR:</strong> Also a treatment but not solely classified as newly approved.</li>\r\n<li><strong>C. TAZACAFTOR:</strong> Similar to lumacaftor; it functions as a corrector but does not stand alone as a newly approved therapy.</li>\r\n</ul>\r\n<p><strong>Key Takeaways:</strong></p>\r\n<ul>\r\n<li><strong>All three therapies</strong> (Ivacaftor, Lumacaftor, and Tezacaftor) are considered newly approved for cystic fibrosis management.</li>\r\n<li>These treatments enhance CFTR function and significantly improve patient outcomes.</li>\r\n</ul>\r\n ",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}